# Leflunomide

NDC: 59651-349
Generic name: Leflunomide
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210329

FDA application: ANDA213652

## Active ingredients

- LEFLUNOMIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-349"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-349
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c358276a-610e-46da-b81a-95c837af205d